#DPHARM2024 is next week! Don’t miss the chance to meet our team, including our new CEO, Steven Herne, and discover the power of the Unlearn Platform™: ➡️ Design smaller, faster, and more efficient trials. ➡️ Generate and visualize digital twins for every participant in your study. ➡️ Use digital twins to estimate the effect of your drug. ➕ And more. 📅 Schedule a meeting here: https://bit.ly/47bEX4K —— Andrew Stelzer; Anurag Kulkarni
Unlearn.AI
Research Services
San Francisco, California 8,965 followers
Advancing AI to eliminate trial and error in medicine.
About us
Advancing artificial intelligence to eliminate trial and error in medicine.
- Website
-
https://www.unlearn.ai/
External link for Unlearn.AI
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- San Francisco, California
- Type
- Privately Held
- Founded
- 2017
- Specialties
- Artificial Intelligence, Biotechnology, Pharmaceuticals, Machine Learning, Clinical Trials, Clinical Research, Computational Biology, Data Science, Biostatistics, Deep Learning, and Machine Learning
Locations
-
Primary
303 2nd St
Suite N460
San Francisco, California 94107, US
-
245 Main Street
2nd Floor
Cambridge, MA 02142, US
Employees at Unlearn.AI
Updates
-
Unlearn.AI reposted this
The competition is fierce and budgets are tight. How do you stand out? Four words: a fire product story. 🔥 Story isn't just about the framework for what you say (although that is a part of it). It's also about reading the room. Taking the time to actually connect with every audience. Delivering your brand or product in a succinct but powerful way that sets you apart from the competition, and sometimes, an industry. Unlearn.AI was a part of the AI industry "before AI became cool." On a mission to help people's lives in one of their most vulnerable moments, they found themselves encountering the rollercoaster of AI interest. 🎢 From the spike of interest in the last few years, to the coined "AI fatigue" some of us are encountering now — through it all, their product story was primed to weather all seasons, including highly skeptical audiences — that yielded growth. 📽 Join us for our next webinar to hear Becky Bausman interview Unlearn's Andrew Stelzer and Duarte Executive Speaker Coach Josh Storie as they unpack how they curated a powerful and tailored product story. #productstory #brandstory #companystorytelling #differentiate #communication
This content isn’t available here
Access this content and more in the LinkedIn app
-
Unlearn.AI reposted this
When we started Unlearn.AI over 7 years ago, I believed that creating AI to simulate biology was the most interesting and impactful unsolved problem. I still do. But as Unlearn has grown, I've been pulled farther away from the hands on research and engineering work I was put on this Earth to do. Earlier this year, I decided it's time to get back to my roots and start inventing stuff again. Today, I'm announcing that I'm stepping down as CEO and starting a new role as Unlearn's Chief Scientist. Excited to get back to building things again! (After a short vacation, of course ;)) Over the past few months, I've gotten to know Steven Herne as our Chief Commercial Officer, and am excited to partner with him as he takes over the CEO role and helps usher in a new era of Unlearning! https://lnkd.in/gK8cJMVz
-
Unlearn.AI reposted this
When we started Unlearn.AI over 7 years ago, I believed that creating AI to simulate biology was the most interesting and impactful unsolved problem. I still do. But as Unlearn has grown, I've been pulled farther away from the hands on research and engineering work I was put on this Earth to do. Earlier this year, I decided it's time to get back to my roots and start inventing stuff again. Today, I'm announcing that I'm stepping down as CEO and starting a new role as Unlearn's Chief Scientist. Excited to get back to building things again! (After a short vacation, of course ;)) Over the past few months, I've gotten to know Steven Herne as our Chief Commercial Officer, and am excited to partner with him as he takes over the CEO role and helps usher in a new era of Unlearning! https://lnkd.in/gK8cJMVz
-
Attending #DPHARM2024? 🔬 Don’t miss our Head of Business Development, Andrew Stelzer, presenting 'Enhancing Clinical Trials with Digital Twins' on September 17 at 11:55 AM ET. He will share insights into how #digitaltwins can transform patient health outcomes, highlight real-world successes with companies like AbbVie and QurAlis, and showcase a live demo of the Unlearn Platform. ➡️ Register now: https://bit.ly/4ggsLnr
-
Ready to help revolutionize #medicine with #AI? Explore our open positions and join us in transforming the future of #healthcare: https://lnkd.in/gqkVbQte 🚀
-
"...The power of AI lies in its ability to reliably gauge the relative impact of multiple pieces of (occasionally conflicting) information to the clinical trajectory of a particular person, pulling the signal from the noise." — Jess Ross, Senior Government Affairs Lead at Unlearn, in the Managed Healthcare Executive article, "Digital Twins Could Be Crystal Balls of Healthcare" by Jared Kaltwasser 🔮 https://lnkd.in/dhBApiBG
Digital Twins Could Be the Crystal Balls of Healthcare
managedhealthcareexecutive.com
-
"Digital twins are the future of medicine. They basically replace our entire medical system; you basically turn medicine into a predictive science, you run experiments, and you optimize patients' treatments" — Charles Fisher in the ZDNET article, "How digital twins could save time, money, and lives in developing prescription drugs" by Tiernan Ray 🚀 https://lnkd.in/gEUdcCVK
How digital twins could save time, money, and lives in developing prescription drugs
zdnet.com
-
Join our team at #DPHARM2024 to explore the Unlearn Platform and discover how we’re helping leading pharma companies optimize #clinicaltrials using participants’ #digitaltwins. Don’t miss the opportunity to see this powerful first-of-its-kind tool in action—enhancing trial efficiency, precision, and delivering patient-specific insights into drug effectiveness. 🗓️ Schedule a time here: https://bit.ly/47bEX4K ——— Andrew Stelzer; Steven Herne; Anurag Kulkarni